1. Home
  2. PLX vs OXSQ Comparison

PLX vs OXSQ Comparison

Compare PLX & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.40

Market Cap

191.0M

Sector

Health Care

ML Signal

HOLD

Logo Oxford Square Capital Corp.

OXSQ

Oxford Square Capital Corp.

HOLD

Current Price

$1.41

Market Cap

164.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLX
OXSQ
Founded
1993
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
191.0M
164.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
PLX
OXSQ
Price
$2.40
$1.41
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
497.2K
1.4M
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
22.83%
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$52,744,000.00
N/A
Revenue This Year
$36.81
$3.61
Revenue Next Year
N/A
N/A
P/E Ratio
$10.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$1.05
52 Week High
$3.19
$2.42

Technical Indicators

Market Signals
Indicator
PLX
OXSQ
Relative Strength Index (RSI) 59.20 45.30
Support Level $2.06 $1.26
Resistance Level $2.44 $1.43
Average True Range (ATR) 0.09 0.06
MACD -0.01 -0.01
Stochastic Oscillator 63.04 10.87

Price Performance

Historical Comparison
PLX
OXSQ

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

About OXSQ Oxford Square Capital Corp.

Oxford Square Capital Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize portfolio's total return. Its primary current focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and, to a lesser extent collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. CLO investments may also include warehouse facilities, which are early-stage CLO vehicles intended to aggregate loans that may be used to form the basis of a traditional CLO vehicle. The company may also invest in publicly traded debt and/or equity securities.

Share on Social Networks: